2McKenna H, Charles J, Holmes M, et al. Novel stent for prevention of restenosis. Trends Cardiovas Med, 1997,7 : 245-249.
3Antonio C, Evangelia K. Biodegradable stents “fulfilling the mission and stepping away”. Circulation, 2000, 102: 371-373.
4Ganesh R,Robert S, Meidell C, et al. Fabrication of bioresorbable microporous intravascular stents for gene therapy. ASAIO J, 1994,40: 489-584.
5Rojas C, Ignacio A, Slunt K, et al. Polyurethane coatings release bioactive antibodies to reduce bacterial adhesion. J Contro Release,2000, 63: 175-189.
6Lemmouchi H, Yahia C, Schacht S, et al. In vitro release of trypanocidal drugs from biodegradable implants based on poly (-caprolactone) and poly(d,l-lactide). J Control Release, 1998, 55:79-85.
7Seifert B, Romaniuk P, Groth TH. Covalent immobilization of hirudin improves the haemocompatibility of polylactide-polyglycolide in vitro. Biomaterials, 1997, 18 : 1495-1502.
8Lahann S, Joerg K, Doris N, et al. Bioactive immobilization of rhirudin on CVD-coated metallic implant devices. Biomaterials,2001,22: 817-826.
9Wetzels C, Gwendolyn MR, Koole L, et al. Photoimmobilisation of poly ( N-vinylpyrrolidinone ) as a means to improve haemocompatibility of polyurethane biomaterials. Biomaterials,1999, 20: 1879-1887.
10Julia HL, Baron P, Anthony H, et al. In vitro evaluation of c7E-Fab( ReoPro^TM ) eluting polymer-coated coronary stents. Cardiovas Res,2000, 46 : 585-594.
